Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FXSR1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,214
Award facts
- Contract value 100% obligated
- $25,214.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,214.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Xeomin 100 Unit Vials, with a completion deadline of January 28, 2026. The contract, which was competitively awarded with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This IDC, valued at up to $999.99 million through December 2031, serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery of Xeomin, a botulinum toxin product used in medical and cosmetic applications, reflects the company's extensive portfolio supplying diverse pharmaceutical products across multiple therapeutic domains to the Department of Defense and related federal healthcare institutions. The firm fixed-price structure and competitive award demonstrate AmerisourceBergen's established capability to meet federal procurement requirements efficiently within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FXSR1?
SPE2DR26FXSR1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FXSR1 worth?
The government has obligated $25,214 on SPE2DR26FXSR1.
Is contract SPE2DR26FXSR1 an order under another contract?
Yes. SPE2DR26FXSR1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXSR1 competed?
The extent of competition for SPE2DR26FXSR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award